Literature DB >> 26923529

Concentration-dependent behaviors of bone marrow derived mesenchymal stem cells and infectious bacteria toward magnesium oxide nanoparticles.

Cheyann Lee Wetteland1, Nhu-Y Thi Nguyen2, Huinan Liu3.   

Abstract

This article reports the quantitative relationship between the concentration of magnesium oxide (MgO) nanoparticles and its distinct biological activities towards mammalian cells and infectious bacteria for the first time. The effects of MgO nanoparticles on the viability of bone marrow derived mesenchymal stem cells (BMSCs) and infectious bacteria (both gram-negative Escherichia coli and gram-positive Staphylococcus epidermidis) showed a concentration-dependent behavior in vitro. The critical concentrations of MgO nanoparticles identified in this study provided valuable guidelines for biomaterial design toward potential clinical translation. BMSCs density increased significantly when cultured in 200μg/mL of MgO in comparison to the Cells Only control without MgO. The density of BMSCs decreased significantly after culture in the media with 500μg/mL or more of MgO. Concentrations at or above 1000μg/mL of MgO resulted in complete BMSCs death. Quantification of colony forming units (CFU) revealed that the minimum bactericidal concentration (MBC) of MgO for E. coli and S. epidermidis was 1200μg/mL. The addition of MgO nanoparticles into the cultures increased the pH and Mg(2+) ion concentration in the respective culture media, which might have played a role in the observed cell responses but not the main factors. E. coli and S. epidermidis still proliferated significantly at alkaline pH up to 10 or with supplemental Mg(2+) dosages up to 50mM, indicating bactericidal properties of MgO are beyond the effects of increased media pH and Mg(2+) ion concentrations. MgO nanoparticles at a concentration of 200μg/mL provided dual benefits of promoting BMSC proliferation while reducing bacterial adhesion, which should be further studied for potential medical implant applications. The use of free MgO nanoparticles yielded detrimental effects to BMSCs in concentrations above 300μg/mL. We recommend further study into MgO nanoparticle as a coating material or as a part of a composite. STATEMENT OF SIGNIFICANCE: This article reports the quantitative relationship between the concentration of magnesium oxide (MgO) nanoparticles and its distinct biological activities towards mammalian cells and infectious bacteria for the first time. The effects of MgO nanoparticles on the viability of bone marrow derived mesenchymal stem cells (BMSCs) and infectious bacteria (both gram-negative Escherichia coli and gram-positive Staphylococcus epidermidis) showed a concentration-dependent behavior in vitro. The critical concentrations of MgO nanoparticles identified in this study provided valuable guidelines for biomaterial design toward potential clinical translation.
Copyright © 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bacteria; Bone marrow derived mesenchymal stem cells (BMSCs); Cytocompatibility; Escherichia coli (E. coli); Magnesium oxide (MgO) nanoparticles; Staphylococcus epidermidis (S. epidermidis); Viability

Mesh:

Substances:

Year:  2016        PMID: 26923529     DOI: 10.1016/j.actbio.2016.02.032

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  11 in total

1.  Cellular behaviours of bone marrow-derived mesenchymal stem cells towards pristine graphene oxide nanosheets.

Authors:  Changbo Wei; Zifeng Liu; Fangfang Jiang; Binghui Zeng; Mingdi Huang; Dongsheng Yu
Journal:  Cell Prolif       Date:  2017-08-03       Impact factor: 6.831

2.  Toxicological assessment of magnesium oxide nanoparticles in HT29 intestinal cells.

Authors:  Anna Mittag; Thomas Schneider; Martin Westermann; Michael Glei
Journal:  Arch Toxicol       Date:  2019-04-15       Impact factor: 5.153

3.  Cytotoxicity Assessment of Surface-Modified Magnesium Hydroxide Nanoparticles.

Authors:  Mónica Echeverry-Rendón; Brina Stančič; Kirsten Muizer; Valentina Duque; Deanne Jennei Calderon; Felix Echeverria; Martin C Harmsen
Journal:  ACS Omega       Date:  2022-05-19

4.  Nano-to-Submicron Hydroxyapatite Coatings for Magnesium-based Bioresorbable Implants - Deposition, Characterization, Degradation, Mechanical Properties, and Cytocompatibility.

Authors:  Qiaomu Tian; Jiajia Lin; Laura Rivera-Castaneda; Amit Tsanhani; Zachary S Dunn; Alexis Rodriguez; Arash Aslani; Huinan Liu
Journal:  Sci Rep       Date:  2019-01-28       Impact factor: 4.379

5.  Antimicrobial Polymeric Composites with Embedded Nanotextured Magnesium Oxide.

Authors:  Nemanja Aničić; Mario Kurtjak; Samo Jeverica; Danilo Suvorov; Marija Vukomanović
Journal:  Polymers (Basel)       Date:  2021-06-30       Impact factor: 4.329

Review 6.  Antibacterial properties and toxicity from metallic nanomaterials.

Authors:  Gina V Vimbela; Sang M Ngo; Carolyn Fraze; Lei Yang; David A Stout
Journal:  Int J Nanomedicine       Date:  2017-05-24

Review 7.  Nanomaterials for treating cardiovascular diseases: A review.

Authors:  Wensen Jiang; Dana Rutherford; Tiffany Vuong; Huinan Liu
Journal:  Bioact Mater       Date:  2017-12-06

8.  Effects of Magnesium Oxide (MgO) Shapes on In Vitro and In Vivo Degradation Behaviors of PLA/MgO Composites in Long Term.

Authors:  Yun Zhao; Hui Liang; Shiqiang Zhang; Shengwei Qu; Yue Jiang; Minfang Chen
Journal:  Polymers (Basel)       Date:  2020-05-08       Impact factor: 4.329

9.  Antimicrobial Activities and Mechanisms of Magnesium Oxide Nanoparticles (nMgO) against Pathogenic Bacteria, Yeasts, and Biofilms.

Authors:  Nhu-Y Thi Nguyen; Nathaniel Grelling; Cheyann Lee Wetteland; Romeo Rosario; Huinan Liu
Journal:  Sci Rep       Date:  2018-11-02       Impact factor: 4.379

10.  The antibacterial and angiogenic effect of magnesium oxide in a hydroxyapatite bone substitute.

Authors:  Catarina C Coelho; Tatiana Padrão; Laura Costa; Marta T Pinto; Paulo C Costa; Valentina F Domingues; Paulo A Quadros; Fernando J Monteiro; Susana R Sousa
Journal:  Sci Rep       Date:  2020-11-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.